Revolutionary progress, like that of GLP-1 drugs, happens when many exceptional people work together, following a robust ...

A collaborative effort between IIT Madras and Ohio State University has led to the creation of a pioneering AI framework, PURE, for generating drug-like molecules efficiently. This breakthrough holds ...

Jo Varshney, PhD, DVM, discusses how artificial intelligence–powered simulations speed drug approvals and reduce clinical ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational therapy being ...

IIT Madras announces the 'PURE' AI framework, promising significant reductions in drug development timelines. Developed with Ohio State University, PURE uses reinforcement learning to optimize ...

Artificial intelligence (AI) is rapidly transforming clinical trials by dramatically reducing timelines and costs, accelerating patient-centered drug development and creating more resilient and ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes as tech ...

The number of medications in development to treat obesity continues to grow, and the drugs can offer health benefits for ...

On October 27, Thermo Fisher Scientific and Lundbeck both announced new collaborations with OpenAI. These moves represent a continuing trend of drug development companies inking deals with technology ...

The draft guidance, which is touted as a way to reduce the cost and time-associated burden of biosimilar development, has ...

In this week’s edition of InnovationRx, we look Nvidia’s collaborations in life sciences and drug development, Cobot’s ...

Can a generic drug designed to make chemotherapy work better benefit people with autism? President Trump is touting an “amazing” drug — leucovorin — as “an answer to autism,” a broad range of ...